Prospective evaluation of erectile dysfunction with a Validated Patient Reported Outcome Measure in patients with Peyronie's disease requiring Nesbit's type surgery.
BAUS ePoster online library. Skrodzka M. 06/23/21; 319040; p13-2
Disclosure(s): NA
Dr. Marta Skrodzka
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Introduction: There are few prospective studies of outcomes of Peyronie's surgery. In studies reporting erectile dysfunction (ED), established tools (SHIM and IIEF) are not validated for Peyronie's disease. We have previously published development of a validated PROM for Nesbit's surgery. In this study we determined the rate and severity of ED pre- and post-operatively.
Patients and Methods: 5year prospective study of patients recruited into Peyronie's PROM development. After a RAND consensus group and pilot PROM, a 4question, 5point (0-4) domain for ED was validated. Scores 0 (no ED) to 16 (very severe ED) were recorded and stratified (mild ED – 5-8, moderate ED – 9-12, severe ED – 13-16) pre- and post-op. Exclusions: Surgery for congenital curvature and grafts. Patients completed the PROM at time of decision for surgery, within a week pre-op, and 12 weeks post-surgery.
Results: 130 men. Median age 57 (25-73). 12 patients excluded for starting ED treatment pre-surgery. Pre-op rates for no-, mild-, moderate- severe ED were 47 (39.8%), 45 (38.1%), 23 (19.5%) and 3 (2.5%). Post op, rates were 56 (47.5%), 43 (36.4%), 19 (16.1%) and 0 men. 93 men (78.8%) were ED treatment naïve pre-op and 79 (66.9%) required no treatment post-op. 24 men (20.3%) had PDE5I treatment prior to presentation and 38 (32.2%) had PDE5I post-op.
Conclusion: We report the first prospective validated PROM assessment of ED in Nesbit's surgery. Surgery did not result in deterioration of erectile function. High rates of pre-existing ED should be managed alongside surgery for satisfactory patient outcome.
Patients and Methods: 5year prospective study of patients recruited into Peyronie's PROM development. After a RAND consensus group and pilot PROM, a 4question, 5point (0-4) domain for ED was validated. Scores 0 (no ED) to 16 (very severe ED) were recorded and stratified (mild ED – 5-8, moderate ED – 9-12, severe ED – 13-16) pre- and post-op. Exclusions: Surgery for congenital curvature and grafts. Patients completed the PROM at time of decision for surgery, within a week pre-op, and 12 weeks post-surgery.
Results: 130 men. Median age 57 (25-73). 12 patients excluded for starting ED treatment pre-surgery. Pre-op rates for no-, mild-, moderate- severe ED were 47 (39.8%), 45 (38.1%), 23 (19.5%) and 3 (2.5%). Post op, rates were 56 (47.5%), 43 (36.4%), 19 (16.1%) and 0 men. 93 men (78.8%) were ED treatment naïve pre-op and 79 (66.9%) required no treatment post-op. 24 men (20.3%) had PDE5I treatment prior to presentation and 38 (32.2%) had PDE5I post-op.
Conclusion: We report the first prospective validated PROM assessment of ED in Nesbit's surgery. Surgery did not result in deterioration of erectile function. High rates of pre-existing ED should be managed alongside surgery for satisfactory patient outcome.
Introduction: There are few prospective studies of outcomes of Peyronie's surgery. In studies reporting erectile dysfunction (ED), established tools (SHIM and IIEF) are not validated for Peyronie's disease. We have previously published development of a validated PROM for Nesbit's surgery. In this study we determined the rate and severity of ED pre- and post-operatively.
Patients and Methods: 5year prospective study of patients recruited into Peyronie's PROM development. After a RAND consensus group and pilot PROM, a 4question, 5point (0-4) domain for ED was validated. Scores 0 (no ED) to 16 (very severe ED) were recorded and stratified (mild ED – 5-8, moderate ED – 9-12, severe ED – 13-16) pre- and post-op. Exclusions: Surgery for congenital curvature and grafts. Patients completed the PROM at time of decision for surgery, within a week pre-op, and 12 weeks post-surgery.
Results: 130 men. Median age 57 (25-73). 12 patients excluded for starting ED treatment pre-surgery. Pre-op rates for no-, mild-, moderate- severe ED were 47 (39.8%), 45 (38.1%), 23 (19.5%) and 3 (2.5%). Post op, rates were 56 (47.5%), 43 (36.4%), 19 (16.1%) and 0 men. 93 men (78.8%) were ED treatment naïve pre-op and 79 (66.9%) required no treatment post-op. 24 men (20.3%) had PDE5I treatment prior to presentation and 38 (32.2%) had PDE5I post-op.
Conclusion: We report the first prospective validated PROM assessment of ED in Nesbit's surgery. Surgery did not result in deterioration of erectile function. High rates of pre-existing ED should be managed alongside surgery for satisfactory patient outcome.
Patients and Methods: 5year prospective study of patients recruited into Peyronie's PROM development. After a RAND consensus group and pilot PROM, a 4question, 5point (0-4) domain for ED was validated. Scores 0 (no ED) to 16 (very severe ED) were recorded and stratified (mild ED – 5-8, moderate ED – 9-12, severe ED – 13-16) pre- and post-op. Exclusions: Surgery for congenital curvature and grafts. Patients completed the PROM at time of decision for surgery, within a week pre-op, and 12 weeks post-surgery.
Results: 130 men. Median age 57 (25-73). 12 patients excluded for starting ED treatment pre-surgery. Pre-op rates for no-, mild-, moderate- severe ED were 47 (39.8%), 45 (38.1%), 23 (19.5%) and 3 (2.5%). Post op, rates were 56 (47.5%), 43 (36.4%), 19 (16.1%) and 0 men. 93 men (78.8%) were ED treatment naïve pre-op and 79 (66.9%) required no treatment post-op. 24 men (20.3%) had PDE5I treatment prior to presentation and 38 (32.2%) had PDE5I post-op.
Conclusion: We report the first prospective validated PROM assessment of ED in Nesbit's surgery. Surgery did not result in deterioration of erectile function. High rates of pre-existing ED should be managed alongside surgery for satisfactory patient outcome.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}